Tag Archive | "ILMN"
Industry Updates, Personalized Medicine
Hot off the presses, Illumina has just lowered prices on its Individual Genome Sequencing services to $19,500 – or $9,500 for patients with serious medical conditions who could benefit.
http://investor.illumina.com/phoenix.zhtml?c=121127&p=irol-newsArticle&ID=1434418
Industry Updates, Personalized Medicine
Xconomy’s Luke Timmerman interviews Illumina CEO Jay Flatley on
innovation, competition and staying on top. Particularly insightful
are his views on the competitive landscape for next-gen sequencing,
bioinformatics and why there aren’t any billion-dollar bioinformatics companies (yet)
and the coming data management challenge in sequence data.
http://www.xconomy.com/san-diego/2010/04/06/illumina-ceo-jay-flatley-on-how-to-keep-an-edge-in-the-fast-paced-world-of-gene-sequencing/?single_page=true
Industry Updates
The San Diego Business Journal summarizes local biotech giants Illumina and Life Technologies’ race to the $1000 genome. Spoiler alert – analysts favor Illumina’s Solexa technology over Life Tech’s SOLiD.
http://www.sdbj.com/article.asp?aID=144667&link=perm
Industry Updates
Two of my favorite biotechs continue their patent battles. This time Illumina succeeded this March in patenting a process that both it and Affymetrix have been using for years.
In high-tech patent battles like this, I always have a hard time deciding if it’s really the companies that cause the dispute or our antiquated patent process [...]
Industry Updates
Local biotech Illumina sees a slowdown in purchasing their large, full genome sequencing systems. However, with their substantial cash reserves the company can afford to play the long game.
http://www.xconomy.com/san-diego/2009/04/22/illumina-anticipates-purchasing-slowdown/